drugset / Trial / NCT02010632

Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products

NCT02010632

Phase 1 Completed 32 enrolled Khon Kaen University
RandomizedCrossoverSingle-blind

Summary

The purpose of this study is to compare the pharmacodynamic effect of clopidogrel on the platelet inhibition and the pharmacokinetic profiles of clopidogrel carboxylic acid metabolite between generic and reference clopidogrel products in Thai healthy volunteers

Timeline

Start
2013-08
Primary completion
2014-10
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg

Indications

No indication recorded.